Dive Brief: Quest Diagnostics launched a consumer-facing version of its AD-Detect test to assess Alzheimer’s disease risk. The test, which costs $399, assesses levels of
What You Should Know: – MedCognetics, Inc., a company focusing on medical imaging AI, today announced the successful testing and implementation of the first embedded AI
In November, EQRx publicly gave up on the final pieces of its low-cost medicines approach. But in a recent financial filing, the company revealed that